Can virtual reality soothe IBS symptoms?

NCT ID NCT05796388

First seen Jun 26, 2026 · Last updated Jul 30, 2026 · Updated 3 times

Summary

This pilot study tests whether adding immersive virtual reality therapy to the standard IBS medication linaclotide can improve symptoms and quality of life more than medication alone. Researchers will enroll 65 adults with IBS-C and compare those getting real VR therapy to those getting a sham VR. The main goal is to see if the combination leads to greater symptom relief after 8 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
linaclotide and virtual reality therapy
What this could lead to
If it works, this could point toward a drug-free add-on therapy to ease IBS symptoms and improve quality of life.
What could go wrong
This is a small, early pilot study with only 65 people. The VR therapy may not provide extra benefit over medication alone, and results may not apply to everyone with IBS-C.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME WITH CONSTIPATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic Florida

    RECRUITING

    Jacksonville, Florida, 32224, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.